Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. cholesterol and recurrent events (CARE) investigators. Ridker, P. M.; Rifai, N.; Pfeffer, M. A.; Sacks, F. M.; Moye, L. A.; Goldman, S.; Flaker, G. C.; and Braunwald, E. Circulation, 98(9):839-44, 1998. Clinical Trial Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't United states
bibtex   
@Article{Ridker_1998_1619,
  author = {Ridker, P. M. and Rifai, N. and Pfeffer, M. A. and Sacks, F. M. and Moye, L. A. and Goldman, S. and Flaker, G. C. and Braunwald, E.},
 journal = {Circulation},
 note = {Clinical Trial Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't United states},
 number = {9},
 pages = {839-44},
 title = {Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. cholesterol and recurrent events (CARE) investigators},
 volume = {98},
 year = {1998},
 keywords = {Aged, Apolipoproteins/metabolism, Arteriosclerosis/blood/drug, therapy/epidemiology, C-Reactive, Protein/metabolism, Cholesterol/*blood, Double-Blind, Method, Female, Humans, Hydroxymethylglutaryl-CoA, Reductase, Inhibitors/*administration, &, dosage, Male, Middle, Aged, Myocardial, Infarction/blood/*drug, therapy/epidemiology, Myocarditis/blood/*drug, therapy/epidemiology, Pravastatin/*administration, &, dosage, Protein, Precursors/metabolism, Recurrence, Risk, Factors, Serum, Amyloid, A, Protein/metabolism},
 title_with_no_special_chars = {Inflammation pravastatin and the risk of coronary events after myocardial infarction in patients with average cholesterol levels Cholesterol and Recurrent Events CARE Investigators}
}
Downloads: 0